Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8IYV

Crystal structure of trypsin-famotidine complex at 2.10 Angstroms resolution

Summary for 8IYV
Entry DOI10.2210/pdb8iyv/pdb
DescriptorCationic trypsin, SULFATE ION, CALCIUM ION, ... (6 entities in total)
Functional Keywordshydrolase
Biological sourceBos taurus (cattle)
Total number of polymer chains1
Total formula weight23835.34
Authors
Ahmad, M.S.,Kalam, N.,Akbar, Z.,Rasheed, S.,Choudhary, M.I. (deposition date: 2023-04-06, release date: 2024-09-18, Last modification date: 2024-10-30)
Primary citationAhmad, M.S.,Kalam, N.,Akbar, Z.,Shah, N.,Rasheed, S.,Choudhary, M.I.
Structural basis for the binding of famotidine, cimetidine, guanidine, and pimagedine with serine protease.
Biochem.Biophys.Res.Commun., 733:150603-150603, 2024
Cited by
PubMed Abstract: Serine proteases are among the important groups of enzymes having significant roles in cell biology. Trypsin is a representative member of the serine superfamily of enzymes, produced by acinar cells of pancreas. It is a validated drug target for various ailments including pancreatitis and colorectal cancer. Premature activation of trypsin is involved in the lysis of pancreatic tissues, which causes pancreatitis. It is also reported to be involved in colorectal carcinoma by activating other proteases, such as matrix metalloproteinase (MMPs). The development of novel trypsin inhibitors with good pharmacokinetic properties could play important roles in pharmaceutical sciences. This study reports the crystal structures of bovine pancreatic trypsin with four molecules; cimetidine, famotidine, pimagedine, and guanidine. These compounds possess binding affinity towards the active site (S1) of trypsin. The structures of all four complexes provided insight of the binding of four different ligands, as well as the dynamics of the active site towards the bind with different size ligands. This study might be helpful in designing of new potent inhibitors of trypsin and trypsin like serine proteases.
PubMed: 39216203
DOI: 10.1016/j.bbrc.2024.150603
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon